Haw Par Corp Ltd
H02
Company Profile
Business description
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.
Contact
401 Commonwealth Drive
No. 03-03 Haw Par Technocentre
Singapore149598
SGPT: +65 63379102
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
595
Stocks News & Analysis
stocks
Chart of the week: Where do our analysts see value?
This week's chart of the week looks at the under and overvalued sectors in the Australian market.
stocks
Attractive ASX opportunity with high yield
This REIT is undervalued after selloff despite interest-rate and vacancy headwinds.
stocks
Top priorities for new ANZ CEO
ANZ Group needs margin and efficiency improvement rather than market share gains.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,586.90 | 23.50 | -0.27% |
| CAC 40 | 7,428.13 | 4.73 | 0.06% |
| DAX 40 | 20,414.31 | 15.15 | 0.07% |
| Dow JONES (US) | 44,075.20 | 73.36 | -0.17% |
| FTSE 100 | 8,308.41 | 6.79 | 0.08% |
| HKSE | 20,397.05 | 242.00 | 1.20% |
| NASDAQ | 19,983.11 | 51.78 | -0.26% |
| Nikkei 225 | 39,849.14 | 476.91 | 1.21% |
| NZX 50 Index | 12,692.72 | 68.47 | -0.54% |
| S&P 500 | 6,072.74 | 11.45 | -0.19% |
| S&P/ASX 200 | 8,330.30 | 23.30 | -0.28% |
| SSE Composite Index | 3,461.50 | 29.01 | 0.85% |